THE DEAL, AT A GLANCE
From the announcementImmuneel Therapeutics
01What it doesImmuneel Therapeutics is a Bengaluru-based Digital Health company focused on Scale CAR-T Therapy.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02Who is involvedBacked by a mix of new, </strong>, Singularity AMC, including founder Kiran Mazumdar-ShawFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03What happenedImmuneel Therapeutics raised Series B, announced 2026-06-08From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗04Why it mattersImmuneel Therapeutics sits in an active Healthcare & Life Sciences funding market, but the recorded $0M Series B limits the financing signal to participation rather than…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Immuneel Therapeutics · Financing Record
Explore source-linked visual explanations for Immuneel Therapeutics. Unsupported claims are withheld while source review continues.
Record 5704 · Recorded date: 2026-06-08
Explore company records →